Insider · SEC Form 4 filer

Perceptive Advisors LLC

Companies

Where they file as an insider

LeonaBio (LONA) Director, 10% owner Latest filing Oct 26, 2026
Lyra Therapeutics (LYRA) 10% owner Latest filing Nov 13, 2025
Acrivon Therapeutics (ACRV) 10% owner Latest filing May 1, 2025
Adagio Medical (ADGM) Director, 10% owner Latest filing Jan 22, 2025
Cerevel Therapeutics (CERE) Director Latest filing Feb 20, 2024
Verrica Pharmaceuticals (VRCA) 10% owner Latest filing Dec 26, 2023
Astria Therapeutics (ATXS) Director Latest filing Dec 21, 2023

Track record

Did their buys beat the typical stock?

Open-market buys1
Quarters checked 6 months later1
Beat the typical stock —
Quarters too new to check0

Too soon to tell. 1 quarter has finished so far. We show a record once 3 have.

Astria Therapeutics (ATXS) Bought Dec 21, 2023 · $4.59M · 740,000 shares Beat typical Dec 31, 2023 $7.68 → Jun 30, 2024 $9.10 · +18.5% (typical stock −1.2%)

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist